Dr. Takakuwa from Translational Research Business Unit to present a poster at the 11th Annual Meeting of Nucleic Acids Therapeutics Society of Japan
Dr. Takakuwa, a researcher from the Translational Research …
Route-Dependent Central Effects and Efficacy Prediction of a Nucleic Acid Drug: Comparison of ICV and IT Administration
The 99th Annual Meeting of the Japanese Pharmacological Society
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug
ACS Medicinal Chemistry Letters
Researcher Yuka Hasegawa from the Translational Research Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology
Yuka Hasegawa, a researcher from the Translational Research …
Gateway – Maximizing Human Predictability from In Vivo Pharmacology Studies
Join this webinar to find out how we can help accelerate your Drug Discovery! our first speaker will provide an overview of these approaches, followed by a case study on anti-obesity drug development presented by our second speaker.
Dr. Qinge Liang, a researcher from the Translational Research Business Unit, will have an oral and a poster presentation at the 53rd Annual Meeting of the Japanese Society of Toxicology
Dr. Qinge Liang, a researcher from the Translational …
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
Fujisawa, Japan, June 18, 2026 — Axcelead Drug …
Researcher Furukawa from the Discovery Technologies Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology (JSOT)
Researcher Furukawa from the Discovery Technologies Business Unit …
Enhancing Clinical Predictability through Human Disease-relevant Preclinical Models in CNS and Muscle Drug Discovery
Drug discovery for central nervous system (CNS) and muscle diseases continues to face major translational challenges. Conventional models often fail to capture human disease biology, while functional readouts can be difficult to reproduce, interpret, and translate into clinically meaningful outcomes.